Search

everythinglearnresearchcommunity

for

Search:↓

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Some drugs for inflammation may cause psoriasis-like hair loss.

Using cidofovir cream for a rare skin disease can cause skin darkening.

TS-13 speeds up hair regrowth after chemotherapy.

Cyclosporine effectively treated a woman's stubborn skin condition.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

A patient with complete hair loss regrew all her hair using tofacitinib.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

The new delivery method for dutasteride is more effective and has fewer side effects.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Keeping human skin stem cells is easier with low temperatures and mTOR inhibition.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Cetuximab can cause excessive eyelash growth.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Activated protein C helps protect mice from radiation damage.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.